Real EHR Experience
for Real World Application

Practice Workflow Expertise: The Miraca Life Science Advantage

As a leading pathology service provider, we’ve always had a focus on technology. We’ve worked with numerous EHR systems, and we have a strong history of providing workflow efficiencies and solutions to our clients. By combining our extensive experience and expertise, we’ve created a technology services solution that assists healthcare professionals in advancing workflow efficiency, and guides them towards full EHR integration to get the connectivity and automation they need to become Meaningful Use compliant.

We also offer a dedicated team of response consultants that have extensive experience working with many of the top EHR solutions in the industry. By doing so, we're creating a far more complete support system to meet your needs — you can always reach someone if you have an issue.

Get connected. Contact us at or 855.EHR.PATH (347.7284) to learn more about the effective methods that we’re using to implement EHR systems into practices every day.

Complete EHR Integration

The integration and application of an EHR system can be daunting. We work with a variety of EHRs on a daily basis, which is why we strive to find the system that is right for you. Our comprehensive workflow assessment is used to determine your needs, and a system comparison is executed to ensure the proper fit with your practice. We provide the data. You choose the system that best optimizes your practice for success in streamlining efficiencies.

We’re engineering ways to make your workflow experience better — maximizing the efficacy and quality of your care, while driving clinical and practice solutions for today and beyond. Through it all, we provide a level of consultative service that supports your practice beyond EHR integration. We work with you through the multiple phases of Meaningful Use compliance as well as others including PQRS and ICD-10. It's a long-term partnership whose focus is on the success and achievement of your practice.

Break through the perceived barriers of EHR integration. Talk with your customer service representative to discover how we can help you find the right EHR system to strengthen your practice.

Our team has worked with a multitude of EHR solutions, including:

  • ADS — Advanced Data Systems
  • Agastha
  • Allscripts
  • Altos Solutions, Inc.
  • Amazing Charts
  • Aprima Medical Software, Inc.
  • Athena Health
  • Atlas Medical
  • Azalea Health Innovations
  • Cerner
  • Criterions
  • e-MDs
  • eClinicalWorks
  • eDerm Systems
  • edgeMED
  • EHI — Enable Healthcare, Inc.
  • Ellkay
  • Emdeon
  • Encite
  • Endosoft/UTECH Products
  • GE Healthcare — Centricity
  • gMed
  • Greenway Medical Technologies, Inc.
  • HalfPenny Technologies, Inc.
  • Henry Schein (MicroMD)
  • Infinite Software Solutions (MD Reports)
  • LMR — Partners Healthcare
  • Lytec
  • MacPractice
  • Medent
  • MedPlus — Care360/Quest
  • Modernizing Medicine
  • NexTech
  • NextGen HealthCare
  • Office Medicine
  • Olympus America, Inc.
  • OPTUMInsight
  • Orchard Software
  • Partners Community Healthcare, Inc.
  • Pentax of America
  • PerfectCare by NCG Medical
  • Practice Fusion
  • Practice Partners
  • Praxis
  • Provation Medical
  • Source Medical
  • STI Computer
  • Varian
  • Vitera Healthcare
  • WEBeDoctor

Choose Miraca for Your Patients

Learn more about Miraca's Anatomic Pathology services

Learn More »

Your dermatopathologists are awesome! It is a huge gift to have your pathologists working with me.
— Kimberly J. Wonderlich, MD,
Wonderlich Dermatology, Fairbanks, Alaska

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News

September 22, 2017

Avista Capital Partners to Acquire Miraca Life Sciences

IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Continue reading press release

Continue reading

April 18, 2017

Miraca Research News: Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

Pathologists at Miraca Life Sciences contributed significantly in the development of a new product from Philips, the IntelliSite Pathology Solution. As one of four clinical study sites, Miraca Life Sciences participated in “one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes.” At Miraca, participation in the Philips study was a project of Miraca […]

Continue reading

April 11, 2017

Ten Research Projects from Miraca Life Sciences Accepted for DDW Conference

IRVING, Texas, April 12, 2017 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Digestive Disease Week® conference (DDW), which will be held May 6–9 in Chicago. DDW is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, […]

Continue reading

March 27, 2017

Simponi® is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life Sciences

IRVING, Texas, March 28, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand its InformTx™ therapeutic drug monitoring (TDM) capabilities, now testing for Simponi (golimumab) as well as patient-developed antibodies to Simponi. This is the first TDM assay available in the United States for Simponi. With this addition, Miraca Life Sciences now performs TDM […]

Continue reading

November 30, 2016

Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life Sciences

IRVING, Texas, December 1, 2016 — Miraca Life Sciences, the largest U.S. independent anatomic pathology lab, has expanded its InformTx™ therapeutic drug monitoring service for drugs that treat inflammatory bowel disease (IBD) with the addition of Stelara (ustekinumab).

Miraca Life Sciences continues to perform therapeutic drug monitoring (TDM) for Remicade® (infliximab), Humira® (adalimumab), Cimzia® (Certolizumab pegol) and Entyvio® (vedolizumab). Since […]

Continue reading